BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21619550)

  • 1. Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage.
    Lian F; Xing X; Yuan G; Schäfer C; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP; Burgermeister E
    Biochem J; 2011 Sep; 438(2):315-23. PubMed ID: 21619550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy.
    Xing X; Burgermeister E; Geisler F; Einwächter H; Fan L; Hiber M; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP
    Hepatology; 2009 Mar; 49(3):979-88. PubMed ID: 19072826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis.
    Mencarelli A; Renga B; Migliorati M; Cipriani S; Distrutti E; Santucci L; Fiorucci S
    J Immunol; 2009 Nov; 183(10):6657-66. PubMed ID: 19880446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes.
    Qin P; Borges-Marcucci LA; Evans MJ; Harnish DC
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G267-73. PubMed ID: 15817812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bile acid receptor FXR is a modulator of intestinal innate immunity.
    Vavassori P; Mencarelli A; Renga B; Distrutti E; Fiorucci S
    J Immunol; 2009 Nov; 183(10):6251-61. PubMed ID: 19864602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VPAC1 expression is regulated by FXR agonists in the human gallbladder epithelium.
    Chignard N; Mergey M; Barbu V; Finzi L; Tiret E; Paul A; Housset C
    Hepatology; 2005 Sep; 42(3):549-57. PubMed ID: 16037943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of ileal bile acid-binding protein expression in Caco-2 cells by ursodeoxycholic acid: role of the farnesoid X receptor.
    Campana G; Pasini P; Roda A; Spampinato S
    Biochem Pharmacol; 2005 Jun; 69(12):1755-63. PubMed ID: 15935148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile salt supplementation acts via the farnesoid X receptor to alleviate lipopolysaccharide-induced intestinal injury.
    Zahiri HR; Perrone EE; Strauch ED
    Surgery; 2011 Sep; 150(3):480-9. PubMed ID: 21878234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of farnesoid X receptor modulators by a fluorescence polarization-based interaction assay.
    Han KC; Kim JH; Kim KH; Kim EE; Seo JH; Yang EG
    Anal Biochem; 2010 Mar; 398(2):185-90. PubMed ID: 19913492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.
    Yang F; Huang X; Yi T; Yen Y; Moore DD; Huang W
    Cancer Res; 2007 Feb; 67(3):863-7. PubMed ID: 17283114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The farnesoid X receptor induces very low density lipoprotein receptor gene expression.
    Sirvent A; Claudel T; Martin G; Brozek J; Kosykh V; Darteil R; Hum DW; Fruchart JC; Staels B
    FEBS Lett; 2004 May; 566(1-3):173-7. PubMed ID: 15147890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
    Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
    Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice.
    Martin IV; Schmitt J; Minkenberg A; Mertens JC; Stieger B; Mullhaupt B; Geier A
    Biol Chem; 2010 Dec; 391(12):1441-9. PubMed ID: 20868235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Farnesoid X receptor up-regulates expression of lipid transfer inhibitor protein in liver cells and mice.
    Li L; Liu H; Peng J; Wang Y; Zhang Y; Dong J; Liu X; Guo D; Jiang Y
    Biochem Biophys Res Commun; 2013 Nov; 441(4):880-5. PubMed ID: 24211198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
    Martínez-Fernández P; Hierro L; Jara P; Alvarez L
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes.
    Landrier JF; Eloranta JJ; Vavricka SR; Kullak-Ublick GA
    Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G476-85. PubMed ID: 16269519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus.
    Capello A; Moons LM; Van de Winkel A; Siersema PD; van Dekken H; Kuipers EJ; Kusters JG
    Am J Gastroenterol; 2008 Jun; 103(6):1510-6. PubMed ID: 18510604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of N-Myc downstream regulated gene 2 by bile acids.
    Langhi C; Pedraz-Cuesta E; Donate Y; Marrero PF; Haro D; Rodríguez JC
    Biochem Biophys Res Commun; 2013 Apr; 434(1):102-9. PubMed ID: 23541942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acid increases expression of the histamine-producing enzyme, histidine decarboxylase, in gastric cells.
    Ku HJ; Kim HY; Kim HH; Park HJ; Cheong JH
    World J Gastroenterol; 2014 Jan; 20(1):175-82. PubMed ID: 24415870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice.
    Fiorucci S; Mencarelli A; Cipriani S; Renga B; Palladino G; Santucci L; Distrutti E
    Br J Pharmacol; 2011 Dec; 164(8):1929-38. PubMed ID: 21564085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.